Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Candor Rx vs eMed

Candor Rx
Graded #63

Higher grade

vs+17.199999999999996
eMed
Graded #399

Lower grade

The verdict

Candor Rx takes it — 74.6/100 to 57.4/100.

Candor Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing marketed as '$95/month, any dose, forever.' Semaglutide starts as…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCandor Rx +50
95
45
Dose & formulationCandor Rx +32
72
40
Clinical oversighteMed +7
76
83
Labs & monitoringeMed +13
52
65
FulfillmentCandor Rx +9
71
62
Contract termsCandor Rx +6
61
55
Candor Rx · left bareMed · right bar

The numbers

MetricCandor RxeMed
WeighScore74.6/10057.4/100
GradeCC
Scorecard rank#63#399
Semaglutide$99/mo (all doses, compounded)Not disclosed
Tirzepatide$149/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Candor Rx

Graded #63 · C

Strengths

  • Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
  • Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
  • Medication ships in about 48 hours and you can cancel anytime
  • Simple, transparent GLP-1 focus with pricing shown up front before signup

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • No LegitScript certification is displayed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
eMed

Graded #399 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where it loses points

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard